Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Bisacodyl is an organic compound that is used as a stimulant laxative drug. It works directly on the colon to produce a bowel movement. It is typically prescribed for relief of episodic and chronic constipation and for the management of neurogenic bowel dysfunction, as well as part of bowel preparation before medical examinations, such as for a colonoscopy.
Read the full article on WikipediaConstipation Clinical criteria: Patient must be paraplegic or quadriplegic or have severe neurogenic impairment of bowel function.
Terminal malignant neoplasia Clinical criteria: Population criteria: Patient must identify as Aboriginal or Torres Strait Islander.
Anorectal congenital abnormalities Clinical criteria: Population criteria: Patient must identify as Aboriginal or Torres Strait Islander.
Megacolon Clinical criteria: Population criteria: Patient must identify as Aboriginal or Torres Strait Islander.
“Bisacodyl works by stimulating enteric neurons to cause peristalsis (i.e., colonic contractions). It is also a contact laxative; it increases fluid and salt secretion. The action of bisacodyl on the small intestine is negligible; stimulant laxatives mainly promote evacuation of the colon.”
“16 hours[citation needed]”
Working under the parallel aged-care framework? Aged-care equivalent →